THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc.

Diagnostics & Research Healthcare Waltham, MA, United States TMO (NYQ) Website
Quarter: Q4 2025 Reported: October 22, 2025

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Stock Performance (90 Days)

Data through Nov 11, 2025
Layoff Events
Earnings Calls

Quick Summary

Thermo Fisher Scientific Inc. (TMO) announced its Q4 2025 financial results for the quarter ended September 27, 2025. While the announcement confirms the release, specific financial performance details and key metrics are not provided in the furnished text.

Sign in for a more detailed summary

Create a free account to access detailed earnings summaries and full transcripts.

Financial Metrics

eps
revenue
guidance
net income

Stock Price

$586.49
TMO· NYQ
1.76%

Company Info

Industry
Diagnostics & Research
Sector
Healthcare
Headquarters
Waltham, MA, United States
CEO
Mr. Marc N. Casper
Employees
125,000

Layoff Stats

Layoff Events
0
Total Affected
0

Financials

Market Cap $220.23B